首页> 外文期刊>International journal of clinical pharmacology and therapeutics >The role of the clinical pharmacist in reducing mortality in hospitalized cardiac patients: A prospective, nonrandomized controlled trial using propensity score methods
【24h】

The role of the clinical pharmacist in reducing mortality in hospitalized cardiac patients: A prospective, nonrandomized controlled trial using propensity score methods

机译:临床药剂师在降低住院心脏病患者死亡率方面的作用:一项使用倾向评分法的前瞻性,非随机对照试验

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: Meta-analyses have suggested that pharmacist-led medication reviews have no discernable effect on patient mortality. These analyses may not have found a statistically significant effect because they did not adequately control for the wide variation in the delivery of care and patient selection parameters. Therefore, a more precise approach to evaluating the effect of clinical pharmacist interventions on the mortality rates of hospitalized cardiac patients is required. Objective: To evaluate the impact of the clinical pharmacist as a direct patient-care team member on the mortality of all patients admitted to cardiology units. Methods: A prospective, nonrandomized observational study compared patients who received standard care with patients admitted to a service that included clinical pharmacists. Propensity score matching was applied to enhance the comparability. The primary endpoint of the study was the composite of all-cause mortality in the study group and the control group. Results: Pharmacists were consulted by physicians to correct any drugrelated issues that they suspected may cause or contribute to a fatal outcome in the cardiology ward. A total of 428 interventions were suggested by the clinical pharmacist in the study group; 375 (87.6%) of them were accepted by the cardiology team. All-cause mortality was 1.8% during phase 1 treatment (preintervention) and was reduced to 1.1% during phase 2 treatment (postintervention); the difference was statistically significant. There was no statistical difference in all-cause mortality in the control unit between phase 1 and phase 2. Results were similar in the propensity score-matched subcohort. Conclusions: Drug-related problems that were suspected to cause or contribute to a possibly fatal outcome were determined by the clinical pharmacist service in patients hospitalized in a cardiology ward. Correction of these drug-related problems by physicians after the pharmacist's advice caused a significant decrease in mortality as analyzed by propensity score matching. The significant reduction in the mortality rate in this patient population observed in this study is "hypothesis generating" for future randomized studies.
机译:背景:荟萃分析表明,药剂师主导的药物审查对患者死亡率没有明显影响。这些分析可能没有发现统计学上的显着效果,因为它们没有充分控制护理服务和患者选择参数的广泛差异。因此,需要一种更精确的方法来评估临床药剂师干预措施对住院心脏病患者死亡率的影响。目的:评估作为直接患者护理团队成员的临床药剂师对所有入院心脏科的患者死亡率的影响。方法:一项前瞻性,非随机的观察性研究将接受标准护理的患者与接受包括临床药剂师服务的患者进行了比较。倾向得分匹配用于增强可比性。研究的主要终点是研究组和对照组的全因死亡率综合。结果:医师咨询了药剂师,以纠正他们怀疑可能导致心脏病病房或导致致命结果的任何药物相关问题。研究组的临床药剂师共建议了428项干预措施。其中375名(87.6%)被心脏病小组接受。在第1阶段治疗(干预前)期间,全因死亡率为1.8%,在第2阶段治疗(干预后)期间降低至1.1%。差异具有统计学意义。在第1阶段和第2阶段之间,对照组的全因死亡率没有统计学差异。在倾向评分匹配的亚人群中,结果相似。结论:怀疑是引起或可能导致致命结果的药物相关问题由心脏病病房住院患者的临床药剂师服务确定。医师根据药师的建议纠正这些与药物有关的问题后,导致死亡率显着降低(通过倾向得分匹配分析)。在这项研究中观察到的该患者群体的死亡率的显着降低对于未来的随机研究是“假说产生”。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号